Crescita Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRRTF research report →
About the company
Crescita Therapeutics Inc. , a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services.
- CEO
- Serge Verreault
- IPO
- 2016
- Employees
- 65
- HQ
- Laval, QC, CA
Price Chart
- Market Cap
- $10.40M
- P/E
- -43.17
- P/S
- 0.63
- P/B
- 1.02
- EV/EBITDA
- 5.58
- Div Yield
- 0.00%
- Gross Margin
- 52.39%
- Op Margin
- -5.02%
- Net Margin
- -1.38%
- ROE
- -2.07%
- ROIC
- -6.87%
- Revenue
- $21.10M · 7.77%
- Net Income
- $-91,924 · 96.66%
- EPS
- $-0.00 · 96.50%
- Op Income
- $-1,021,166
- FCF YoY
- -51.99%
- 52W High
- $0.57
- 52W Low
- $0.02
- 50D MA
- $0.55
- 200D MA
- $0.38
- Beta
- -0.12
- Avg Volume
- 2.20K
Get TickerSpark's AI analysis on CRRTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CRRTF coverage
Recent articles, reports, and earnings notes.
No research on CRRTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRRTF report →Similar companies
Peers in the same neighborhood.